% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

  • buyermarkers buyermarkers Jun 2, 2013 5:43 PM Flag

    DAVITA Investors are buying Rockwell.They realize the True Value of share & Importance

    Investors in Davita are now purchasing shares as the Phase 3 cruise trial reached the trial end period.Davita only profits as does Rockwell with their lead drug technology (sfp) and have proven safe and reliable products to Davita as seen with the major increase just awarded to Rockwell for Citripure.With (sfp) the new state of the art Iron delivery technology for Davita patients,the #2 dialysis provider in the U.S. we already see the benefits and unmet medical need currently in the dialysis providing clinics.Patients were not feeling better for no reason and it was attributed to new technology as investors now can clearly see if you calculate the changes accordingly.The marker for the endpoint most likely will be reached if one just does the past comparisons or has someone knowledgeable to assist them with past results.They are now ready for production of Calcitriol and Davita is already on board to buy the drug/D Vit as the Food and Drug Administration only has to verify the stability testing Rockwell has done and passed before the fast approval drug filing was made in the past and could be approved right after they meet the endpoints in the cruise study results.With Rockwell's advancement in the dialysis space,Davita only proves to become more profitable as they can offer (sfp) and Calcitriol to their patients at far better pricing than competitors as they will be the largest supplier of these products first as agreements signed.A licence agreement may come at any time now that the trials are finished,for outside the U.S. market.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
11.97-0.16(-1.32%)Dec 1 4:00 PMEST